Summit Global Investments Invests $103,000 in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Summit Global Investments bought a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 22,587 shares of the company’s stock, valued at approximately $103,000.

Several other large investors have also recently added to or reduced their stakes in the business. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in Aveanna Healthcare by 15.7% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 25,171 shares of the company’s stock valued at $115,000 after buying an additional 3,407 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of Aveanna Healthcare by 0.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company’s stock worth $2,133,000 after acquiring an additional 4,047 shares during the last quarter. SG Americas Securities LLC grew its holdings in Aveanna Healthcare by 26.0% in the fourth quarter. SG Americas Securities LLC now owns 24,366 shares of the company’s stock valued at $111,000 after purchasing an additional 5,031 shares during the period. Intech Investment Management LLC increased its position in Aveanna Healthcare by 42.0% during the fourth quarter. Intech Investment Management LLC now owns 18,813 shares of the company’s stock worth $86,000 after purchasing an additional 5,566 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in Aveanna Healthcare by 11.1% during the fourth quarter. Rhumbline Advisers now owns 72,663 shares of the company’s stock worth $332,000 after purchasing an additional 7,257 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $5.51, for a total value of $339,217.64. Following the transaction, the insider now owns 1,453,948 shares in the company, valued at approximately $8,011,253.48. This represents a 4.06 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 7.80% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

AVAH has been the subject of a number of research analyst reports. UBS Group upped their price objective on Aveanna Healthcare from $3.20 to $4.50 and gave the stock a “sell” rating in a report on Friday, March 14th. Truist Financial reduced their price objective on Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating on the stock in a research note on Monday, January 6th.

Aveanna Healthcare Price Performance

Aveanna Healthcare stock opened at $5.50 on Wednesday. Aveanna Healthcare Holdings Inc. has a 12-month low of $2.11 and a 12-month high of $6.19. The stock has a market capitalization of $1.07 billion, a PE ratio of -16.18 and a beta of 2.25. The firm has a 50 day simple moving average of $4.69 and a 200-day simple moving average of $4.95.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.